Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 4/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.53 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrogen SCHEMBL28594721 | 0.96 | LTA4H (0.91) | LTA4HSIGMAR1CA4MEN1KMT2A | |
| SCHEMBL5551078 | 0.94 | LTA4H (0.88) | LTA4HSIGMAR1CA4MEN1KMT2A | |
| SCHEMBL27884 | 0.90 | LTA4H (0.81) | LTA4HIDO1SAE1UBA2CA12 | |
| SCHEMBL25986524 | 0.90 | LTA4H (0.81) | LTA4HIDO1SAE1UBA2CA12 | |
| SCHEMBL1425001 | 0.90 | LTA4H (0.81) | LTA4HIDO1SAE1UBA2CA12 | |
| SCHEMBL27666880 | 0.90 | LTA4H (0.81) | LTA4HSIGMAR1CA4MEN1KMT2A | |
| SCHEMBL11819224 | 0.89 | LTA4H (0.80) | LTA4HSIGMAR1CA4KMT2ARAB9A | |
| Sulfuric Acid SCHEMBL29799164 | 0.88 | LTA4H (0.78) | LTA4HSIGMAR1MEN1KMT2AHTT | |
| SCHEMBL28875158 | 0.88 | LTA4H (0.78) | LTA4HSIGMAR1MEN1KMT2AHTT | |
| Ammonia Solution, Strong SCHEMBL20919857 | 0.87 | LTA4H (0.77) | LTA4HIDO1SAE1UBA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117836304-A | Improved oligonucleotide synthesis | 巴克姆股份公司 | 2024-04-05 | — | — | CN | claimed |
| CN-114249786-A | Preparation and application of nucleoside intermediate containing N, N-diacyl structure | 上海彩迩文生化科技有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-113429307-A | Preparation method and application of stable isotope labeled glutamic acid and glutamic acid derivative | 深圳鼎邦生物科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-107790186-B | Novel decamethyl cyclopentadienyl zirconium complex and preparation method and application thereof | 山西医科大学 | 2020-10-30 | — | — | CN | claimed |
| CN-106565517-B | A method of amide is prepared by arylmethane derivative and nitrile | 湖南大学 | 2018-08-17 | — | — | CN | claimed |
| CN-106565517-A | Method for preparing amide from aryl methane derivative and nitrile | 湖南大学 | 2017-04-19 | — | — | CN | claimed |
| EP-2702041-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | Chiesi Farmaceutici S.p.A. (IT) | 2014-03-05 | — | — | EP | claimed |
| US-8604015-B2 | Alkaloid ester and carbamate derivatives and medicinal compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-12-10 | — | — | US | claimed |
| US-8492384-B2 | Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | claimed |
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-11-01 | — | — | US | claimed |
| US-4566996-A | Process for preparing azetidinone derivatives | Otsuke Kagaku Yakuhin Kabushiki Kaisha (JP) | 1986-01-28 | — | — | US | claimed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | claimed |
| US-4181733-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-01-01 | — | — | US | claimed |
| US-4167630-A | Process for epimerizing beta-lactam antibiotic compounds, and related products | MERCK & CO., INC. (US) | 1979-09-11 | — | — | US | claimed |
| US-4107432-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1978-08-15 | — | — | US | claimed |
| US-4058661-A | 7-Diacyl cephalosporins | MERCK & CO., INC. (US) | 1977-11-15 | — | — | US | claimed |
| US-4053286-A | ACYLATION | MERCK & CO., INC. (US) | 1977-10-11 | — | — | US | claimed |
| US-4051132-A | Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench | MERCK & CO., INC. (US) | 1977-09-27 | — | — | US | claimed |
| US-4014873-A | Process for the production of 7-acylamidocephalosporins | MERCK & CO., INC. (US) | 1977-03-29 | — | — | US | claimed |
| US-3932393-A | 3-Methylenecephalosporins and process for production thereof | ELI LILLY AND COMPANY (US) | 1976-01-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHRM3, BCHE, CHRM1 | LTA4H 324/4885SIGMAR1 1448/4885CA4 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.